Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
基本信息
- 批准号:8210908
- 负责人:
- 金额:$ 35.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:3-nitrotyrosineATP2A2AbbreviationsAccountingAcuteAffectAnimalsAntibodiesAntioxidantsAreaArgentinaAtrial Natriuretic FactorBiochemicalBiochemistryBiogenesisBioinformaticsBiological MarkersBiological PreservationBiologyBiopsyBlood specimenBrain natriuretic peptideCardiacCardiac MyocytesCardiomyopathiesCardiovascular systemCellular MorphologyCellular biologyCessation of lifeChagas DiseaseCharacteristicsChronicChronic DiseaseClassificationClinicalCollaborationsCombined Modality TherapyCommunicable DiseasesComplexCreatine KinaseCreatinineCross-Sectional StudiesCustomDataDatabasesDefectDevelopmentDiseaseDisease susceptibilityEchocardiographyElectrocardiogramEngineeringEnrollmentEnsureEnvironmentEnzymesEquilibriumEtiologyEvolutionExhibitsExperimental ModelsExtracellular MatrixFibrosisFluorescenceFunctional disorderGene ExpressionGene ProteinsGenesGlutamatesGlutathioneGlutathione DisulfideGoalsHealthHeartHeart failureHomeostasisHospitalsHumanIndividualInfectionInjuryInstitutesIntegration Host FactorsInternationalJointsLaboratoriesLeadLeft Ventricular FunctionLeft ventricular structureLiquid ChromatographyLiquid substanceLuxonMalondialdehydeManganese Superoxide DismutaseMetabolicMetabolismMexicoMitochondriaMitochondrial ProteinsMolecularMusMyocardialMyosin Heavy ChainsNADH dehydrogenase (ubiquinone)OrganOutputOxaloacetatesOxidantsOxidative StressOxidoreductaseParasite ControlParasitesPathogenesisPathologicPathologic ProcessesPathologistPathologyPathway interactionsPatientsPatternPerformancePeripheralPeripheral Blood Mononuclear CellPharmaceutical PreparationsPhasePhosphotransferasesPlasmaPlasma ProteinsPlayPositioning AttributePredispositionPreventionProcessProductionProteinsProteomeProtocols documentationPyruvateReactive Oxygen SpeciesReagentReduced GlutathioneResearchRespiratory ChainReticulumRiskRisk FactorsRoleSamplingScientistSerologic testsSeverity of illnessSignal TransductionSiteStagingStructureSymptomsSystemTestingTissuesTrainingTransaminasesTroponinTrypanosomaTrypanosoma cruziVentricular RemodelingWestern Blottingbasebiological adaptation to stresscell injurycombinatorialcomparativedesigndisability-adjusted life yearsexperiencegel electrophoresisglutathione peroxidaseheart functionheart rhythmhuman morbidityhuman subjectinnovationinorganic phosphateinsightmitochondrial dysfunctionmortalitynitronenoveloxidationoxidative damageperipheral bloodphenyl-N-tert-butylnitronepreventrespiratoryresponsescreeningtwo-dimensionalubiquinol
项目摘要
DESCRIPTION (provided by applicant): Chronic chagasic cardiomyopathy (CCM) is a major cause for heart failure related mortality and morbidity of humans. Trypanosoma cruzi is the etiological agent, however, clinical disease does not correlate with parasite presence, and host factors are likely involved in activation and/or sustenance of CCM pathogenesis. In recent studies, we have shown that chagasic animals and patients sustain mitochondrial dysfunction of respiratory chain. At functional level, mitochondrial damage resulted in a decrease in energy output and an increase in oxidative stress both of which can play a pivotal role in cardiovascular homeostasis associated with CCM. Thus, in this proposal, we plan to investigate the critical importance of mitochondrial dysfunction and oxidative stress in human Chagas disease severity. Our central hypothesis is that infection by T. cruzi elicits mt damage in cardiomyocytes that results in a continuing cycle of respiratory chain inefficiency and ROS formation. These ROS cause cellular oxidative damage, and lead to the development of progressive cardiac pathology and impaired LV function in human chagasic patients. To test this hypothesis, we will conduct a cross-sectional study with following specific aims: 1) Identify the molecular, biochemical, and functional changes in mt that cause impaired metabolic activity and constitute a risk factor in human Chagas disease, 2) Determine how ROS-induced oxidative cellular damage enhance the patients' risk to develop clinical symptoms of Chagas disease, and 3) Identify the molecular pathways that are affected by mt and cellular oxidative stress and contribute to myocardial structural and functional alterations during progressive CCM. Samples from cardiomyopathy patients of other etiologies and healthy subjects will be analyzed for comparison purposes. Upon completion of the proposed studies, we anticipate demonstrating the importance of oxidative stress in instigation and/or sustenance of pathological processes (mt metabolic alterations, oxidative processes, cardiac remodeling) during CCM development. The comparative analysis with cardiomyopathy patients of other etiologies would provide insight into the mechanisms of cardiomyopathy development, and identify whether inhibiting oxidative responses would be useful in preventing cardiac damage. We anticipate identifying novel targets for the development of combinatorial therapies for preserving the cardiomyocyte composition and heart function that will be useful in controlling the onset/progression of chronic cardiomyopathy. We will conduct these studies in collaboration with multiple national and international collaborators, and as a result, our collaborators at the Argentina study site will gain training in cutting edge molecular and biochemical approaches, thus, enhancing their research capabilities in cardiovascular infectious diseases.
描述(由申请方提供):慢性肥厚性心肌病(CCM)是人类心力衰竭相关死亡率和发病率的主要原因。克氏锥虫是病原体,然而,临床疾病与寄生虫的存在无关,宿主因素可能参与CCM发病机制的激活和/或维持。近年来的研究表明,哮喘动物和患者存在呼吸链线粒体功能障碍。在功能水平上,线粒体损伤导致能量输出减少和氧化应激增加,这两者都可以在CCM相关的心血管稳态中发挥关键作用。因此,在本提案中,我们计划研究线粒体功能障碍和氧化应激在人类恰加斯病严重程度中的重要性。我们的中心假设是T. cruzi eliminated心肌细胞损伤,导致呼吸链效率低下和ROS形成的持续循环。这些ROS引起细胞氧化损伤,并导致人类chagglutinase患者中进行性心脏病理学的发展和LV功能受损。为了验证这一假设,我们将进行一项具有以下特定目标的横断面研究:1)鉴定引起代谢活性受损并构成人类恰加斯病风险因素的mt的分子、生物化学和功能变化,2)确定ROS诱导的氧化细胞损伤如何增加患者发展恰加斯病临床症状的风险,和3)确定受mt和细胞氧化应激影响的分子途径,并在进行性CCM期间促成心肌结构和功能改变。出于比较目的,将分析其他病因的心肌病患者和健康受试者的样本。在完成拟定研究后,我们预计将证明CCM发展期间氧化应激在激发和/或维持病理过程(mt代谢改变、氧化过程、心脏重塑)中的重要性。与其他病因的心肌病患者的比较分析将深入了解心肌病发展的机制,并确定抑制氧化反应是否有助于预防心脏损伤。我们期望确定新的目标,为发展的组合疗法,以保持心肌细胞的组成和心脏功能,这将是有用的,在控制慢性心肌病的发作/进展。我们将与多个国家和国际合作者合作开展这些研究,因此,我们在阿根廷研究中心的合作者将获得尖端分子和生物化学方法的培训,从而提高他们在心血管传染病方面的研究能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nisha Jain Garg其他文献
NADPH Oxidase: Role in Progression of Myocarditis During Trypanosoma cruzi Infection and Chagas Disease
- DOI:
10.1016/j.freeradbiomed.2010.10.393 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Nisha Jain Garg;Monisha Dhiman - 通讯作者:
Monisha Dhiman
Nisha Jain Garg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nisha Jain Garg', 18)}}的其他基金
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
Mitochondrial Biomarkers of Cardiomyopathy and Cure in Chagas Disease
心肌病的线粒体生物标志物和恰加斯病的治疗
- 批准号:
8666721 - 财政年份:2013
- 资助金额:
$ 35.82万 - 项目类别:
Mitochondrial Biomarkers of Cardiomyopathy and Cure in Chagas Disease
心肌病的线粒体生物标志物和恰加斯病的治疗
- 批准号:
8568036 - 财政年份:2013
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
7994825 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
7567886 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
9751200 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
9571194 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
10219916 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
- 批准号:
7752870 - 财政年份:2009
- 资助金额:
$ 35.82万 - 项目类别:
Human serum carbonyl proteome in cardiovascular diseases
心血管疾病中的人血清羰基蛋白质组
- 批准号:
7530425 - 财政年份:2008
- 资助金额:
$ 35.82万 - 项目类别:
相似国自然基金
TMEM8B-a 多聚化修饰降解 ATP2A2 蛋白抑制肺癌细胞集体侵袭的分子机制及靶向抑制剂转化应用研究
- 批准号:2022JJ10096
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于单细胞测序解析miR-4632靶向ATP2A2调控NLRP3焦亡信号促进肺动脉高压血管重塑的作用机制研究
- 批准号:82241015
- 批准年份:2022
- 资助金额:50.00 万元
- 项目类别:专项项目
TMEM8B-a多聚化修饰降解ATP2A2蛋白抑制肺癌细胞集体侵袭的分子机制及相应靶向抑制剂转化应用研究
- 批准号:82172879
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
重度智力障碍并癫痫候选易感/致病基因ATP2A2、RYR1和RYR2分析验证及发病机制的研究
- 批准号:81771408
- 批准年份:2017
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
A Tbx5-Atp2a2 gene regulatory network for cardiac rhythm - Resubmission 01
心律的 Tbx5-Atp2a2 基因调控网络 - 重新提交 01
- 批准号:
9761177 - 财政年份:2019
- 资助金额:
$ 35.82万 - 项目类别:
ATP2A2-Regulated Keretinocyted Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
- 批准号:
8914890 - 财政年份:2006
- 资助金额:
$ 35.82万 - 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
- 批准号:
7139719 - 财政年份:2006
- 资助金额:
$ 35.82万 - 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
- 批准号:
7482363 - 财政年份:2006
- 资助金额:
$ 35.82万 - 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
- 批准号:
7283820 - 财政年份:2006
- 资助金额:
$ 35.82万 - 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
- 批准号:
7910681 - 财政年份:2006
- 资助金额:
$ 35.82万 - 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
- 批准号:
7669110 - 财政年份:2006
- 资助金额:
$ 35.82万 - 项目类别:














{{item.name}}会员




